Literature DB >> 11484455

[Takayasu's disease: interest in methotrexate treatment].

L Besson-Léaud1, N Grenier, M Besson-Léaud, C Boniface, J M Guillard.   

Abstract

UNLABELLED: Takayasu's disease is a nonspecific aortic arteritis that affects mostly young women and sometimes children. Usual treatment consists of early and prolonged steroids. Some patients do not respond to this treatment, become steroid-dependent or suffer from side effects. We report a case in which methotrexate proved to be effective. CASE REPORT: A 6-year-old girl presented with Takayasu's disease with elevated blood pressure of renovascular origin. Corticosteroids controlled the inflammatory syndrome but not the renal involvement and stopped the growth. Methotrexate (10 mg/m2/week) resulted in the control of the disease, the reduction of steroids and normal growth.
CONCLUSION: In Takayasu's disease, steroids should be given as first-line therapy. In case of failure, side effects or steroid dependency, small doses of methotrexate may facilitate the disease's control and weaning from the steroids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484455     DOI: 10.1016/s0929-693x(00)90305-1

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis.

Authors:  Samuel K Shinjo; Rosa M R Pereira; Vivian A P Tizziani; Ari S Radu; Maurício Levy-Neto
Journal:  Clin Rheumatol       Date:  2007-02-28       Impact factor: 2.980

2.  Takayasu arteritis in children.

Authors:  Safia Al Abrawi; Marine Fouillet-Desjonqueres; Louis David; Xavier Barral; Pierre Cochat; Rolando Cimaz
Journal:  Pediatr Rheumatol Online J       Date:  2008-09-28       Impact factor: 3.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.